Healthcare Sector

MRK

Market Tracker

$85.75
-0.23
(-0.27%)
8:00 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
11/07/2025 CALL $89.00 4,711 +4,066 +630.39%
11/07/2025 CALL $86.00 1,781 +1,399 +366.23%
11/14/2025 CALL $85.00 1,754 +1,035 +143.95%
01/15/2027 PUT $75.00 3,343 +673 +25.21%
11/21/2025 CALL $88.00 1,171 +647 +123.47%
01/16/2026 CALL $90.00 27,009 +510 +1.92%
01/16/2026 PUT $80.00 6,534 -40 -0.61%
12/19/2025 PUT $65.00 5,992 -41 -0.68%
11/14/2025 PUT $83.00 114 -44 -27.85%
11/21/2025 CALL $95.00 12,637 -50 -0.39%
01/16/2026 PUT $75.00 10,426 -96 -0.91%
01/16/2026 CALL $100.00 18,495 -258 -1.38%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

    10/31 07:00 am

    GlobeNewswire Inc.

    Read more
  • Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

    10/31 06:19 am

    Benzinga

    Read more
  • Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook

    10/30 12:24 pm

    Benzinga

    Read more
  • Cell-based Assays Market Size to Reach USD 35.34 Billion by 2032, Driven by Demand for Drug Discovery and Advanced Biotechnology Research – SNS Insider

    10/30 04:59 am

    GlobeNewswire Inc.

    Read more
  • Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population

    10/29 11:00 am

    GlobeNewswire Inc.

    Read more
  • Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer

    10/28 01:40 pm

    Benzinga

    Read more
  • Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

    10/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • Healthcare M&A Activity Increases 7% in Q3:25

    10/27 11:38 am

    Benzinga

    Read more
  • 3 Healthcare Stocks That Are Screaming Deals Right Now

    10/26 04:23 pm

    The Motley Fool

    Read more
  • Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally

    10/23 04:08 pm

    The Motley Fool

    Read more
  • Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

    10/22 01:10 pm

    The Motley Fool

    Read more
  • HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment

    10/22 09:00 am

    GlobeNewswire Inc.

    Read more
  • Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA® (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer

    10/21 07:00 am

    GlobeNewswire Inc.

    Read more
  • Small Cell Lung Cancer Market Research 2025-2035: Growth Driven by Advancements in Novel Therapies, Including Immunotherapies, Targeted Therapies, and Combination Treatments

    10/21 04:41 am

    GlobeNewswire Inc.

    Read more
  • What's Going On With Summit Therapeutics Stock On Monday?

    10/20 10:05 am

    Benzinga

    Read more
  • 2 Beaten-Down Stocks to Buy and Hold for the Next Decade

    10/20 09:07 am

    The Motley Fool

    Read more
  • Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients

    10/16 10:33 am

    Benzinga

    Read more
  • Is Recursion Pharmaceuticals a Millionaire Maker?

    10/16 09:31 am

    The Motley Fool

    Read more
  • Why Moderna Might Be a One-Hit Wonder

    10/15 04:08 pm

    The Motley Fool

    Read more
  • Merck's New HIV Treatment Works As Well As Top Drug In Late Trials

    10/15 12:23 pm

    Benzinga

    Read more
  • Absci Stock Offers High-Risk AI Biotech Exposure With 110% Upside Forecast

    10/14 11:41 am

    Investing.com

    Read more
  • Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?

    10/13 06:10 am

    The Motley Fool

    Read more
  • The Best Dividend ETF to Invest $1,000 in Right Now

    10/12 01:05 pm

    The Motley Fool

    Read more
  • Molecule Therapeutics Market Size, Companies and Emerging Technologies Insight – Towards Healthcare

    10/10 09:00 am

    GlobeNewswire Inc.

    Read more
  • MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    10/08 02:59 pm

    GlobeNewswire Inc.

    Read more
  • Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine

    10/07 02:02 pm

    Benzinga

    Read more
  • Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

    10/06 04:05 pm

    Benzinga

    Read more
  • Viral Vector Gene Therapy Market Size Expects to Reach USD 38.39 Billion by 2034

    10/06 11:00 am

    GlobeNewswire Inc.

    Read more
  • Preclinical Advanced Cell Models Market Segmentations and Regional Focused Report (2025 – 2034)

    10/06 09:00 am

    GlobeNewswire Inc.

    Read more
  • Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting

    10/03 09:00 am

    GlobeNewswire Inc.

    Read more
  • 6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal

    10/02 12:15 pm

    Investing.com

    Read more
  • Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

    10/02 11:37 am

    The Motley Fool

    Read more
  • Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting

    10/02 09:00 am

    GlobeNewswire Inc.

    Read more
  • Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients

    09/30 09:47 am

    Benzinga

    Read more
  • 2 Beaten-Down Stocks to Buy and Hold for a Decade

    09/30 07:30 am

    The Motley Fool

    Read more
  • Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

    09/29 04:54 pm

    GlobeNewswire Inc.

    Read more
  • Phosphoramidites Market Research and Forecast Report 2025-2035: Essential Role in DNA/RNA Synthesis Drives Growth in Gene Therapy, Molecular Diagnostics and Personalized Medicine

    09/29 05:53 am

    GlobeNewswire Inc.

    Read more
  • Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

    09/26 12:08 am

    Benzinga

    Read more
  • Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

    09/24 04:05 pm

    Benzinga

    Read more
  • United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO

    09/24 02:15 pm

    Benzinga

    Read more
  • Pneumococcal Vaccine Market Opportunities and Strategies to 2034 - Pediatric Segment Holds the Major Opportunity in Market Expansion

    09/24 12:48 pm

    GlobeNewswire Inc.

    Read more
  • FDA Clears Merck's One-Minute Cancer Shot

    09/22 01:23 pm

    Benzinga

    Read more
  • Advancing Cancer Research Brings New Hope for Patients Worldwide

    09/17 08:30 am

    Benzinga

    Read more
  • HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

    09/16 08:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Healthcare Dividend Stocks to Buy and Hold

    09/14 07:15 am

    The Motley Fool

    Read more
  • Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

    09/08 08:28 am

    Benzinga

    Read more
  • Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025

    09/08 08:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: